- Bed Bath & Beyond Inc. stock price today and history
Please, Signup (Login) to subscribe or trade (demo)
Bed Bath & Beyond Inc. stock price
Bed Bath & Beyond Inc. latest news:
WATCH: About 175,000 UGG comforters recalled due to risk of mold exposure
The U.S. Consumer Product Safety Commission announced today that Bed Bath & Beyond has voluntarily recalled about 175,000 UGG comforters due to the risk of mold exposure.
Bed Bath & Beyond recalls 175,000 Hudson Comforters by UGG because of mold risk
Bed Bath & Beyond Inc. is recalling about 175,000 Hudson Comforters by UGG because of the risk that they contain mold, the U.S. Consumer Products Safety Commission said Thursday. "Mold can be present, posing a risk of respiratory or other infections in individuals with compromised immune systems, damaged lungs or an allergy to mold," the CPSC said in a statement. Consumers should stop using the comforters and return them for a full refund. Bed Batch & Beyond has created a hotline at 800-462-3966. The recall involves polyester comforters sold in four colors and three sizes between August 2017 and October 2017. The comforters were made by BHF International Ltd of Hong Kong in mainland China. Bed Bath & Beyond shares were slightly lower Thursday, and have fallen 43% in the last 12 months, while the S&P 500 has gained 23%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Bed Bath & Beyond shares tumble 12.3% after "weak" earnings announcement
Bed Bath & Beyond Inc. shares fell 12.3% in Thursday trading after the home goods retailer reported third-quarter earnings that Credit Suisse analysts call "weak." Earnings per share of 44 cents beat the 37-cents FactSet consensus, but were down from 85 cents last year. Earnings before interest and taxes (EBIT) was down 350 basis points, "the largest decline to date, validating our concerns on the rising cost of doing business in this sector." Credit Suisse rates Bed Bath & Beyond shares neutral with a $25 price target. KeyBanc Capital Markets also highlighted the "significant competitive headwinds" that will put pressure on the margins over the near-term. "Factors that have pressured results in recent years are likely to continue," analysts wrote. KeyBanc rates Bed Bath & Beyond shares underweight with a $17 price target. "[M]anagement highlighted that it is going to place more emphasis on its value proposition to consumers, including returning to price match guarantees, more responsive pricing at the brick & mortar stores, and adding more low-priced/treasure hunt items to emulate concepts that have succeeded in the current environment such as dollar stores," wrote BTIG analysts. They rate the company's shares neutral. Bed Bath & Beyond shares are down 52.7% for the past year while the S&P 500 index is up 18.8% for the period.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
BRIEF-Bed Bath & Beyond Q3 Earnings Per Share $0.44
Bed Bath & Beyond Inc(BBBY): * REPORTS RESULTS FOR FISCAL 2017 THIRD QUARTER. * Q3 EARNINGS PER SHARE $0.44. * Q3 SALES $3.0 BILLION VERSUS I/B/E/S VIEW $2.9 BILLION. * Q3 SAME STORE SALES FELL 0.3 PERCENT.
Bel Fuse Inc.BELFA
Bel Fuse Inc.BELFB
Bellerophon Therapeutics, Inc.BLPH
Bellicum Pharmaceuticals, Inc.BLCM
Beneficial Bancorp, Inc.BNCL
Benitec Biopharma LimitedBNTC
Benitec Biopharma LimitedBNTCW
BG Medicine, Inc.BGMD
BGC Partners, Inc.BGCP